Patent Assignment
Reel/Frame 061176/0914
Release of Security Interest
Recorded: 2022-08-15
Pages: 10
Assignor
MIDCAP FUNDING IV TRUST
Executed: 2022-08-15
Assignees
RADIUS HEALTH, INC.
22 BOSTON WHARF ROAD, 7TH FLOOR, BOSTON, MASSACHUSETTS, 02210
RADIUS PHARMACEUTICALS, INC.
22 BOSTON WHARF ROAD, 7TH FLOOR, BOSTON, MASSACHUSETTS, 02210
Covered Properties
(52)
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Application:
16/041,416 →
Publication:
US US20190083421A1
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Application:
16/549,828 →
Publication:
US US20200009084A1
Methods for Treating Cancer
Application:
15/794,774 →
Publication:
US US20180153828A1
Methods for Treating Cancer
Methods for Treating Cancer
Application:
15/794,861 →
Publication:
US US20180169101A1
Methods For Treating Cancer
Application:
16/545,859 →
Publication:
US US20200046655A1
Methods For Treating Ovarian Cancer
Application:
16/336,358 →
Publication:
US US20200009085A1
Estrogen Receptor-Modulating Compounds
Methods for Treating Cancer
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Application:
16/986,492 →
Publication:
US US20200368184A1
Polymorphic Forms of RAD1901-2HCL
Formulations of Pthrp Analogues, Transdermal Patches Thereof, and Uses Thereof
Application:
15/948,953 →
Publication:
US US20190091138A1
Abaloparatide Formulations and Methods of Testing, Storing, Modifying, and Using Same
Methods of Improving Spinal Fusion with Abaloparatide
Application:
62/899,633 →
Treatment of Long Bone Fractures with Abaloparatide
Application:
63/134,027 →
Method of Treating Osteoporosis Comprising Administration of Pthrp Analog
Patent:
49,444 →
Application:
17/133,968 →
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES
Application:
17/008,603 →
Publication:
US US20210052705A1
Formulations of Abaloparatide, Transdermal Patches Thereof, and Uses Thereof
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
Application:
16/903,256 →
Publication:
US US20200376088A1
Stable Cannabinoid Formulations
Stable Cannabinoid Formulations
Stable Cannabinoid Formulations
Application:
15/166,476 →
Publication:
US US20160271252A1
Stable Cannabinoid Formulations
Application:
15/253,010 →
Publication:
US US20160367496A1
Stable Cannabinoid Formulations
Stable Cannabinoid Formulations
Methods of Manufacturing Cannabidiol and Intermediates of Manufacturing Cannabidiol
Application:
62/846,279 →
Methods of Manufacturing Cannabidiol or Cannabidivarin and Intermediates of Manufacturing Cannabidiol or Cannabidivarin
Application:
16/870,637 →
Publication:
US US20200354297A1
Cannabidiol Nanocrystal Compositions
Application:
62/856,526 →
Cannabidiol Nanocrystal Compositions
Application:
16/874,300 →
Publication:
US US20200375911A1
Self-Emulsifying Cannabidiol Formulations
Application:
62/847,991 →
Self-Emulsifying Cannabidiol Formulations
Selective Androgen Receptor Modulators
Selective Androgen Receptor Modulators
Selective Estrogen Receptor Modulator
Selective Estrogen Receptor Modulator
Selective Estrogen Receptor Modulator
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Treatment of vasomotor symptoms with selective estrogen receptor modulators
Polymorphic Forms of RAD1901-2HCL
Polymorphic Forms of RAD1901-2HCL
Therapeutic Regimens
Method of Treating Osteoporosis Comprising Administration of Pthrp Analog
A Stable Composition Comprising a Pthrp Analogue
Method of Drug Delivery for Bone Anabolic Protein
Formulations of Abaloparatide, Transdermal Patches Thereof, and Uses Thereof
Polymorphic Forms of RAD1901-2HCL
Elacestrant in Combination with Abemaciclib in Women with Breast Cancer
PCT:
PCT/US2019/063239 ↗
Methods for Treating Cancer in Models Harboring ESR1 Mutations
PCT:
PCT/US2019/064980 ↗
Processes and Compounds
PCT:
PCT/US2020/017777 ↗
Estrogen Receptor-Modulating Compounds
PCT:
PCT/US2020/042903 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 3, 2016
From: INSYS PHARMA, INC.
To: INSYS DEVELOPMENT COMPANY, INC.
Reel/Frame 037652/0049 →
Assignment of Assignor's Interest
Sep 27, 2016
From: VANGARA, KIRAN KUMAR; LI, HUAGUANG; YAN, NINGXIN; NGUYEN, HUNG Q
To: INSYS DEVELOPMENT COMPANY, INC.
Reel/Frame 039865/0701 →
Assignment of Assignor's Interest
May 9, 2018
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 045758/0500 →
Assignment of Assignor's Interest
Sep 11, 2018
From: WARDELL, SUZANNE E.; NELSON, ERIK R.; MCDONNELL, DONALD P.
To: DUKE UNIVERSITY
Reel/Frame 046837/0206 →
Assignment of Assignor's Interest
Jan 2, 2019
From: HARRIS, ALAN; SAEH, JAMAL; HAMED, EHAB; HATTERSLEY, GARY
To: RADIUS HEALTH, INC.
Reel/Frame 047881/0346 →
Assignment of Assignor's Interest
Jan 2, 2019
From: RADIUS HEALTH, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 047881/0490 →
Assignment of Assignor's Interest
Apr 10, 2019
From: GARNER, FIONA
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 048850/0162 →
Assignment of Assignor's Interest
Apr 11, 2019
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 048860/0425 →
Assignment of Assignor's Interest
Aug 21, 2019
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 050117/0127 →
Assignment of Assignor's Interest
Aug 30, 2019
From: WARDELL, SUZANNE E.; NELSON, ERIK R.; MCDONNELL, DONALD P.
To: DUKE UNIVERSITY
Reel/Frame 050226/0625 →
Assignment of Assignor's Interest
Sep 24, 2019
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 050476/0098 →
Assignment of Assignor's Interest
Oct 24, 2019
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 050816/0911 →
Assignment of Assignor's Interest
Nov 27, 2019
From: INSYS THERAPEUTICS, INC.; INSYS PHARMA, INC.; INSYS DEVELOPMENT COMPANY, INC.
To: FRESH CUT DEVELOPMENT, LLC
Reel/Frame 051133/0750 →
Assignment of Assignor's Interest
Nov 29, 2019
From: FRESH CUT DEVELOPMENT, LLC
To: BENUVIA THERAPEUTICS INC.
Reel/Frame 051138/0032 →
Assignment of Assignor's Interest
Dec 2, 2019
From: INSYS THERAPEUTICS, INC; INSYS PHARMA, INC.; INSYS DEVELOPMENT COMPANY, INC.
To: FRESH CUT DEVELOPMENT, LLC
Reel/Frame 051151/0685 →
Assignment of Assignor's Interest
Dec 2, 2019
From: FRESH CUT DEVELOPMENT, LLC
To: BENUVIA THERAPEUTICS INC.
Reel/Frame 051151/0852 →
Assignment of Assignor's Interest
Dec 9, 2019
From: BROWN, KENNETH; DOHMEIER, DANIEL; MOSEMAN, JOAN; ZHANG, YING
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 051215/0641 →
Assignment of Assignor's Interest
Dec 19, 2019
From: BENUVIA THERAPEUTICS INC.
To: FRESH CUT DEVELOPMENT, LLC
Reel/Frame 051381/0283 →
Security Interest (Term)
Jan 15, 2020
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 051618/0200 →
Security Interest (Revolving)
Jan 15, 2020
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 051618/0758 →
Assignment of Assignor's Interest
Feb 18, 2020
From: HATTERSLEY, GARY; HARRIS, ALAN; SAEH, JAMAL; HAMED, EHAB
To: RADIUS HEALTH, INC.
Reel/Frame 051840/0486 →
Assignment of Assignor's Interest
Feb 18, 2020
From: HATTERSLEY, GARY; HARRIS, ALAN; SAEH, JAMAL; HAMED, EHAB
To: RADIUS HEALTH, INC.
Reel/Frame 051842/0435 →
Assignment of Assignor's Interest
Feb 18, 2020
From: BROWN, KENNETH; DOHMEIER, DANIEL; MOSEMAN, JOAN; ZHANG, YING
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 051841/0675 →
Assignment of Assignor's Interest
Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
Assignment of Intellectual Property Security Agreement
Jul 6, 2020
From: MIDCAP FINANCIAL TRUST
To: MIDCAP FUNDING IV TRUST
Reel/Frame 053131/0465 →